MAP2K7 and T-cell acute lymphoblastic leukemia: Moreover, repression in MEK and PI3K-AKT pathways could synergistically inhibited the proliferation of BaF3 cells, expressing IL7RA, JAK, and RAS mutants and was cytotoxic to primary T-cell acute lymphoblastic leukemia (48).